Evidence map›Paper›PMID 34404915›Full record

ReviewMolecular psychiatry2022

Influences of dopaminergic system dysfunction on late-life depression.

Warren D Taylor, David H Zald, Jennifer C Felger, Seth Christman, Daniel O Claassen, Guillermo Horga, Jeffrey M Miller, Katherine Gifford, Baxter Rogers, Sarah M Szymkowicz and 1 more

Open access · greenAbstract readReview
In one paragraph

Review in Molecular psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. The role of dopamine decline, astrocyte reactivity and cerebral small-vessel disease in cognitive aging.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
  7. Targeting mechanisms of change as a path to precision psychotherapy for community settings.Psychotherapy research : journal of the Society for Psychotherapy Research · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Trajectories of late-life depression: insights from molecular imaging.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  12. Article
  13. Article
  14. Remission is insufficient: predictors and mechanistic models of recurrence in late-life depression.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Warren D TaylorDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, USA. warren.d.taylor@vanderbilt.edu.ORCID http://orcid.org/0000-0002-9975-3082
David H ZaldDepartment of Psychiatry Rutgers Biomedical and Health Sciences, Rutgers University, Piscataway, NJ, USA.
Jennifer C FelgerDepartment of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA, USA.
Seth ChristmanDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.
Daniel O ClaassenDepartment of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
Guillermo HorgaDepartment of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons and New York State Psychiatric Institute, New York, NY, USA.
Jeffrey M MillerDepartment of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons and New York State Psychiatric Institute, New York, NY, USA.
Katherine GiffordDepartment of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
Baxter RogersDepartment of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID http://orcid.org/0000-0002-5666-2797
Sarah M SzymkowiczDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.
Bret R RutherfordDepartment of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons and New York State Psychiatric Institute, New York, NY, USA.
Vanderbilt University Medical Center · USNew York State Psychiatric InstituteEmory University · USRutgers, The State University of New Jersey · USVA Tennessee Valley Healthcare System · US

Funding

Expansion of the Dopaminergic Dysfunction in Late-Life Depression Study (The D3 Study)R01MH123662 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI TAYLOR, WARREN D · 2020 to 2024
$7.4M
1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)R01MH123660 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI RUTHERFORD, BRET R · 2020 to 2021
$1.6M
Mentoring and Research on Neurobiological Markers of Clinical Outcomes in DepressionK24MH110598 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI TAYLOR, WARREN D · 2016 to 2019
$637k
Mentoring to Develop Aging-Informed Patient-Oriented Research in NeuropsychiatryK24MH122514 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI RUTHERFORD, BRET R · 2021 to 2021
$167k
NIMH NIH HHS K24 MH110598NIMH NIH HHS K24 MH122514NIMH NIH HHS R01 MH123660NIMH NIH HHS R01 MH123662
6 · The paper itself

Abstract

Deficits in cognition, reward processing, and motor function are clinical features relevant to both aging and depression. Individuals with late-life depression often show impairment across these domains, all of which are moderated by the functioning of dopaminergic circuits. As dopaminergic function declines with normal aging and increased inflammatory burden, the role of dopamine may be particularly salient for late-life depression. We review the literature examining the role of dopamine in the pathogenesis of depression, as well as how dopamine function changes with aging and is influenced by inflammation. Applying a Research Domain Criteria (RDoC) Initiative perspective, we then review work examining how dopaminergic signaling affects these domains, specifically focusing on Cognitive, Positive Valence, and Sensorimotor Systems. We propose a unified model incorporating the effects of aging and low-grade inflammation on dopaminergic functioning, with a resulting negative effect on cognition, reward processing, and motor function. Interplay between these systems may influence development of a depressive phenotype, with an initial deficit in one domain reinforcing decline in others. This model extends RDoC concepts into late-life depression while also providing opportunities for novel and personalized interventions.

Indexed as

DepressionDopamineCognitionRewardDopamine

Identifiers

PMID34404915
PMCPMC8850529
OpenAlexW3195142114

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.